Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Plasma complement biomarkers distinguish multiple sclerosis and neuromyelitis optica spectrum disorder.
Activation of the astrocytic Nrf2/ARE system ameliorates the formation of demyelinating lesions in a multiple sclerosis animal model.
Low serum uric acid levels in patients with multiple sclerosis and neuromyelitis optica: An updated meta-analysis.
Immunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropathies.
Ubiquitination of RORγt at Lysine 446 Limits Th17 Differentiation by Controlling Coactivator Recruitment.
Familial amyotrophic lateral sclerosis with an I104F mutation in the SOD1 gene: Multisystem degeneration with neurofilamentous aggregates and SOD1 inclusions.
Upregulation of CD4+T-Cell Derived MiR-223 in The Relapsing Phase of Multiple Sclerosis Patients.
Diffusion tensor microscopy data (15.6 μm in-plane) of white matter tracts in the human, pig, and rat spinal cord with corresponding tissue histology.
Evaluation of the benefits of treatment with TENS for neurological lower urinary tract dysfunctions.
Tiam1/Rac1 complex controls Il17a transcription and autoimmunity.
Alemtuzumab treatment alters circulating innate immune cells in multiple sclerosis.
Gait Profile Score in multiple sclerosis patients with low disability.
IL4I1 augments CNS remyelination and axonal protection by modulating T cell driven inflammation.
Efficient presentation of myelin oligodendrocyte glycoprotein peptides but not protein by astrocytes from HLA-DR2 and HLA-DR4 transgenic mice.
Changing EDSS Progression in Placebo Cohorts in Relapsing MS: A Systematic Review and Meta-Regression.
Protein Citrullination: A Proposed Mechanism for Pathology in Traumatic Brain Injury.
Bone And Soft Tissue Changes In Patients With Spinal Cord Injury And Multiple Sclerosis.
Age at onset and seizure frequency affect white matter diffusion coefficient in patients with mesial temporal lobe epilepsy.
Association between Helicobacter pylori infection and multiple sclerosis: A systematic review and meta-analysis.
Cystine/glutamate antiporter blockage induces myelin degeneration.
Symptom Management and Lifestyle Modifications in Multiple Sclerosis.
Sphingosine-1-Phosphate (S1P) and S1P Signaling Pathway: Therapeutic Targets in Autoimmunity and Inflammation.
Relationship of Obesity With Gait and Balance in People With Multiple Sclerosis.
Slowly eroding lesions in multiple sclerosis.
Glutamate signalling: A multifaceted modulator of oligodendrocyte lineage cells in health and disease.
Pages
« first
‹ previous
…
813
814
815
816
817
818
819
820
821
…
next ›
last »